MELISSA RUTKIN: Open Payments
NPI 1255008504 · DOYLESTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,930 in 84 payments from 27 companies in 2025. Trend: 2023 $6,868 · 2024 $3,201 · 2025 $6,930
Speaker / faculty: $5,100Food & beverage: $1,830
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 13 | $5,100 |
| BETA BIONICS, INC. | 4 | $236 |
| Amgen Inc. | 6 | $179 |
| Dexcom, Inc. | 7 | $153 |
| Corcept Therapeutics | 5 | $140 |
| Novo Nordisk Inc | 7 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $128 |
| Lilly USA, LLC | 6 | $109 |
| TOLMAR, INC. | 5 | $97 |
| Astellas Pharma US Inc | 2 | $61 |
Products named: OMNIPOD, iLet Bionic Pancreas, EVENITY, Dexcom G6 Transmitter, JARDIANCE, Korlym, JATENZO, MOUNJARO.
Industry payments across PA — which companies pay providers there.
